Page 63 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine The novel index and osteoradionecrosis

doi: 10.1016/j.ejca.2021.03.043 doi: 10.1007/s00066-023-02119-0
19. Fucà G, Beninato T, Bini M, et al. The pan-immune- 30. Khoo SC, Nabil S, Fauzi AA, Yunus SSM, Ngeow WC,
inflammation value in patients with metastatic melanoma Ramli R. Predictors of osteoradionecrosis following
receiving first-line therapy. Target Oncol. 2021;16:529-536. irradiated tooth extraction. Radiat Oncol. 2021;16:130.
doi: 10.1007/s11523-021-00819-0 doi: 10.1186/s13014-021-01851-0
20. Zhang L, Xing R, Huang Z, et al. Synovial fibrosis involvement 31. White SC, Pharoah MJ. Oral Radiology-E-Book: Principles
in osteoarthritis. Front Med (Lausanne). 2021;8:684389. and Interpretation. 8 ed. St. Louis, Missouri: Elsevier; 2018.
th
doi: 10.3389/fmed.2021.684389 32. Buglione M, Cavagnini R, Di Rosario F, et al. Oral toxicity
21. Harth M, Nielson WR. Pain and affective distress in arthritis: management in head and neck cancer patients treated
Relationship to immunity and inflammation. Expert Rev with chemotherapy and radiation: Dental pathologies and
Clin Immunol. 2019;15:541-552. osteoradionecrosis (Part 1) literature review and consensus
statement. Crit Rev Oncol Hematol. 2016;97:131-142.
doi: 10.1080/1744666X.2019.1573675
doi: 10.1016/j.critrevonc.2015.08.010
22. Bhargava D, Jain M, Deshpande A, Singh A, Jaiswal J.
Temporomandibular joint arthrocentesis for internal 33. Dhanda J, Pasquier D, Newman L, Shaw R. Current concepts
derangement with disc displacement without reduction. in osteoradionecrosis after head and neck radiotherapy. Clin
J Maxillofac Oral Surg. 2015;14:454-459. Oncol (R Coll Radiol). 2016;28:459-466.
doi: 10.1007/s12663-012-0447-6 doi: 10.1016/j.clon.2016.03.002
23. Reher P, Doan N, Bradnock B, Meghji S, Harris M. Effect of 34. Chrcanovic BR, Reher P, Sousa AA, Harris M.
ultrasound on the production of IL-8, basic FGF and VEGF. Osteoradionecrosis of the jaws--a current overview--part 1:
Cytokine. 1999;11:416-423. Physiopathology and risk and predisposing factors. Oral
Maxillofac Surg. 2010;14:3-16.
doi: 10.1006/cyto.1998.0444
doi: 10.1007/s10006-009-0198-9
24. Albisinni S, Pretot D, Al Hajj Obeid W, et al. The impact
of neutrophil-to-lymphocyte, platelet-to-lymphocyte 35. Notani K, Yamazaki Y, Kitada H, et al. Management of
and haemoglobin-to-platelet ratio on localised renal cell mandibular osteoradionecrosis corresponding to the severity
carcinoma oncologic outcomes. Prog Urol. 2019;29:423-431. of osteoradionecrosis and the method of radiotherapy. Head
Neck. 2003;25:181-186.
doi: 10.1016/j.purol.2019.05.008
doi: 10.1002/hed.10171
25. Beresford MJ, Burcombe R, Ah-See ML, Stott D, Makris A.
Pre-treatment haemoglobin levels and the prediction of 36. Xu J, Zheng Z, Fang D, et al. Early-stage pathogenic sequence
response to neoadjuvant chemotherapy in breast cancer. of jaw osteoradionecrosis in vivo. J Dent Res. 2012;91:
Clin Oncol (R Coll Radiol). 2006;18:453-458. 702-708.
doi: 10.1016/j.clon.2006.04.006 doi: 10.1177/0022034512448661
26. Mo CJ, Hu ZJ, Qin SZ, et al. Diagnostic value of platelet- 37. Chapchay K, Weinberger J, Eliashar R, Adler N. Anterior
lymphocyte ratio and hemoglobin-platelet ratio in patients skull base reconstruction following ablative surgery for
with rectal cancer. J Clin Lab Anal. 2020;34:e23153. osteoradionecrosis: Case report and review of literature.
Ann Otol Rhinol Laryngol. 2019;128:1134-1140.
doi: 10.1002/jcla.23153
doi: 10.1177/0003489419865558
27. Koga DH, Salvajoli JV, Alves FA. Dental extractions and
radiotherapy in head and neck oncology: Review of the 38. Davis DD, Hanley ME, Cooper JS. Osteoradionecrosis.
literature. Oral Dis. 2008;14:40-44. In: StatPearls. Treasure Island, FL: StatPearls Publishing;
2022. Available from: https://www.ncbi.nlm.nih.gov/books/
doi: 10.1111/j.1601-0825.2006.01351.x
NBK430818 [Last accessed on 2022 May 09].
28. Beech NM, Porceddu S, Bats tone MD. Radiotherapy- 39. Davì G, Patrono C. Platelet activation and atherothrombosis.
associated dental extractions and osteoradionecrosis. Head N Engl J Med. 2007;357:2482-2494.
Neck. 2017;39:128-132.
doi: 10.1056/NEJMra071014
doi: 10.1002/hed.24553
40. Curi MM, Dib LL. Osteoradionecrosis of the jaws:
29. Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B,
Selek U. Utility of pre-chemoradiotherapy pan-immune- A retrospective study of the background factors and
inflammation-value for predicting the osteoradionecrosis treatment in 104 cases. J Oral Maxillofac Surg. 1997;55:540-
rates in locally advanced nasopharyngeal cancers. 544; discussion 545-546.
Strahlenther Onkol. 2023;11:910-921. 41. Schuurhuis JM, Stokman MA, Witjes MJ, Dijkstra PU,

Volume 3 Issue 1 (2025) 55 doi: 10.36922/arnm.5799